Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Preclinical anticancer activity of MEK1 inhibitor E-6201 detailed at AACR

April 23, 2009

Novel, orally active c-MET inhibitor discovered at Lilly: LY-2801653

April 23, 2009

PharmaMar's alkaloid PM-01183 active in vivo, enters phase I investigation

April 23, 2009

Chugai and Roche describe development, preclinical and clinical investigation of CH-4987655

April 23, 2009

SpePharm launches MuGard and Xerotin in Europe

April 23, 2009

Adenovirus-based prostate-specific antigen vaccine enters phase II trials for prostate cancer

April 23, 2009

Dendreon begins phase I trial of D-3263 in advanced cancer

April 22, 2009

EMD Serono identifies new pyridazinone c-MET kinase inhibitors

April 22, 2009

Novel humanized antibody with in vivo antitumor activity developed by Epitomics

April 22, 2009

Novel inhibitor of p21-activated kinase disclosed by Pfizer with potential use as anticancer agent

April 22, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...